Compare IDEXX Laboratories, Inc. (IDXX) vs Iron Mountain Inc (IRM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Iron Mountain Inc — how do they compare? IDEXX Laboratories, Inc. trades at $518.98 (market cap $40.43B), while Iron Mountain Inc trades at $114.1 (market cap $34.46B). The key difference: IDEXX Laboratories, Inc. is the larger of the two by market cap, and Iron Mountain Inc pays a 2.99% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Iron Mountain Inc for 80 Days on average.
| IDXX | IRM | |
|---|---|---|
Market Cap | $40.43B | $34.46B |
Volume | 692,164 | 1,379,608 |
Sector | Health | Real Estate |
52-Week High | $766.68 | $133.06 |
52-Week Low | $504.70 | $78.86 |
Typical Hold Time | 46 Days | 80 Days |
Enterprise Value | $41.32B | $53.87B |
Dividend Yield | — | 2.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $519.87, up 2.61% on the day, with a bearish technical signal from moving averages but strong fundamentals including a 25.03% net income margin and consistent earnings beats. Revenue grew to $4.3B in 2025, and the company recently acquired CoVetAI to enhance veterinary workflow intelligence, signaling strategic expansion.
The stock's outlook is supported by robust profitability and analyst consensus, but faces headwinds from technical weakness and potential market volatility. With a $665 price target implying significant upside, the primary risks include competitive pressures and execution of growth initiatives amid economic uncertainties.
Iron Mountain (IRM) trades at $114.51, down 1.05% on the day, with a bearish technical signal and elevated valuation metrics like a P/E of 82.09. Recent earnings have consistently beaten estimates, with Q2 2026 EPS of $0.60 surpassing the $0.543 forecast. The company is expanding its data center pipeline and digital solutions, targeting 300MW capacity, while revenue grew to $6.90 billion in 2025. However, net income margin has declined to 2.09%, and debt-to-asset ratio rose to 79.04% in 2025, indicating financial leverage concerns.
The outlook is mixed: strong analyst consensus with a $142.75 price target and 66.7% buy ratings support upside potential, but high debt, margin pressure, and bearish technicals pose risks. Growth in data centers and digital services offers opportunity, yet investors must weigh leverage and profitability trends against expansion prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Iron Mountain Inc
Iron Mountain Inc is a record management services provider. The firm is organized as a REIT. Most of its revenue comes from its storage business, with the rest coming from value-added services. The firm primarily caters to enterprise clients in developed markets. Its business segments include Global RIM Business
Read more on IRM →
